Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

Library CD
Volume 9, 2005 CD
Six back issues from 2005 on one convenient CD.
Permanent storage and easy retrieval of IJPC articles and formulations.
Only $95 per CD
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

This CD contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 9 No. 1 January/February 2005 Sterile Preparations
Vol. 9 No. 2 March/April 2005 Health and Wellness
Vol. 9 No. 3 May/June 2005 Veterinary Compounding
Vol. 9 No. 4 July/August 2005 Human Hormone Replacement Therapy
Vol. 9 No. 5 September/October 2005 Pain Management
Vol. 9 No. 6 November/December 2005 Pediatrics

Volume 9, 2005 CD ARTICLES

Volume9, 2005 CD ARTICLES
Title (Click for Details) Vol/Issue Page
PreScription: CompoundingToday.com and Sources of Compounding Chemicals Vol. 9 No. 1 2
Book Review: The Medical & Surgical Practice of NaProTECHNOLOGY Vol. 9 No. 1 5
Literature Reviews Vol. 9 No. 1 5
USP Chapter <797>: Practical Solutions for Microbiology, Sterility, and Pyrogen Testing Vol. 9 No. 1 11
Using ACDs in the Practice of Pharmacy Vol. 9 No. 1 15
USP Chapter <797> and Preparing for a JCAHO Survey Vol. 9 No. 1 23
Questions and Answers: USP Chapter <797> and JCAHO Compliance Vol. 9 No. 1 29
A Dialogue Concerning Contamination Control Systems: Where Does the Isolator Fit In? Vol. 9 No. 1 33
The Marketing Equation Your Ad Man Doesn't Want You to Know: How to Double Your Bottom Line without Spending an Extra Dime Vol. 9 No. 1 37
Defining Success Vol. 9 No. 1 42
The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List") Vol. 9 No. 1 44
Quality-Control Analytical Methods: Microbial Testing Aspects of USP <797> for Compounded Sterile Preparations Vol. 9 No. 1 47
Wish You Were Here: Pharmacy Museum, Weimar, Texas Vol. 9 No. 1 50
Barrier Isolators, Isolators, and Glove Boxes--What's the Difference? Vol. 9 No. 1 53
Calculations Vol. 9 No. 1 57
Basics of Compounding with Acids Vol. 9 No. 1 58
Standard Operating Procedure: Compounding with Concentrated Acids Vol. 9 No. 1 61
Amitriptyline Hydrochloride 10-mg/mL Injection Vol. 9 No. 1 62
Fentanyl 15-mg/mL Injection, Preservative Free Vol. 9 No. 1 63
Gabapentin 2-mg/mL Injection, Preservative Free Vol. 9 No. 1 64
Guaifenesin 50-mg/mL Injection Vol. 9 No. 1 65
Lidocaine Hydrochloride-2%, Ketolorac Tromethamine-3%, and Clonidine Hydrochloride-0.1% Injection Vol. 9 No. 1 66
Naltrexone Hydrochloride 1.4-mg/mL Injection, Preservative Free Vol. 9 No. 1 67
Naproxen Sodium 100-mg/mL Injection Vol. 9 No. 1 68
Phenol 8% Injection Vol. 9 No. 1 69
Tolazoline Hydrochloride 25-mg/mL Injection Vol. 9 No. 1 70
Tramadol Hydrochloride 50-mg/mL Injection, Preservative Free Vol. 9 No. 1 71
Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature Vol. 9 No. 1 72
Physical characteristics of selected over-the-counter medications Vol. 9 No. 1 75
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Vol. 9 No. 1 82
Scientific and Professional Reviewers for 2004 Vol. 9 No. 1 87
PostScription: Pharmacy, Pharmacists, and Pharmacy Practice Vol. 9 No. 1 88
Prescription: Too Much Information? Vol. 9 No. 2 90
Book Review: Bacteria for Breakfast: Probiotics for Good Health Vol. 9 No. 2 93
Book Review: Miracle Cure: How to Solve America's Health Care Crisis and Why Canada Isn't the Answer Vol. 9 No. 2 93
Literature Reviews Vol. 9 No. 2 94
N-acetylcysteine Used to Decrease the Incidence of Contrast-Induced Nephropathy Following Radiographic Procedures: A Literature Review Vol. 9 No. 2 99
Treatment of Mercury Intoxication With Dimercaptopropanesulfonate Vol. 9 No. 2 105
What a Pharmacist Needs to Know about Bariatric Surgery: Compounding Opportunities Vol. 9 No. 2 111
Combating Cardiovascular Disease With Compounded Medications. Part 1: Combination Cardiac Medicines to Control Blood Pressure Vol. 9 No. 2 117
Use of Domperidone as a Prokinetic and Antiemetic Vol. 9 No. 2 120
Proposed Revisions to USP Chapter <797> Pharmaceutical Compounding--Sterile Preparations Vol. 9 No. 2 127
Communication Makes It or Breaks It Vol. 9 No. 2 133
Quality-Control Analytical Methods: Chemical Testing Aspects of USP <797> for Compounded Sterile Preparations Vol. 9 No. 2 136
Basics of Compounding for Hair Care--Part I: Medicated Shampoos Vol. 9 No. 2 140
Standard Operating Procedure: SOP Master Book--Maintenance Vol. 9 No. 2 145
Calculations Vol. 9 No. 2 146
Aspirin 30-mg/mL Desensitization Oral Liquid, Nonaqueous Vol. 9 No. 2 147
Capsaicin 0.2-mg Troches Vol. 9 No. 2 148
Clobetasol Topical Spray Vol. 9 No. 2 149
Clobetasol and Dyclonine Oral Paste Vol. 9 No. 2 150
Homatropine 3-mg Rapid Dissolving Tablets Vol. 9 No. 2 151
Isosorbide Dinitrate 0.1% Topical Spray Vol. 9 No. 2 152
Sildenafil 1% Vaginal Cream or Gel Vol. 9 No. 2 153
Sildenafil Vaginal Suppository Vol. 9 No. 2 154
Silver Sulfadiazine 1% and Fluriprofen 2% Cream Vol. 9 No. 2 155
Thiabendazole 15% Cream Vol. 9 No. 2 156
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride Vol. 9 No. 2 157
Chemical Stability of Isoniazid in an Oral Liquid Dosage Form Vol. 9 No. 2 165
PostScription: Experts Everywhere Vol. 9 No. 2 167
PreScription: Working Together: Lessons from a Rope Vol. 9 No. 3 170
Book Reviews: Veterinary Drug Handbook: Client Information Edition Vol. 9 No. 3 173
Book Reviews: When Change Is Your Company's Middle Name: The Professional's Guide to Understanding the Human Side of Business Transformation Vol. 9 No. 3 173
Literature Reviews Vol. 9 No. 3 174
Update on Transdermals for Animal Patients Vol. 9 No. 3 178
Compounding for Behavior Problems in Animals Vol. 9 No. 3 185
Compounding Antiangiogenic Cancer Therapy for Animals Vol. 9 No. 3 195
Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Vol. 9 No. 3 201
Quality-Control Analytical Methods: Determination of Tapped Bulk Volume for Compounded Prescriptions Vol. 9 No. 3 207
Survey of State Veterinary Compounding Laws and Regulations Vol. 9 No. 3 209
What Customers Want Vol. 9 No. 3 213
Basics of Compounding for Hair Care -- Part 2: Medicated Conditions Vol. 9 No. 3 215
Pharmacy History: Pharmacy Knots Vol. 9 No. 3 220
Standard Operating Procedure: Exhaust System Airflow Monitoring (Individual Capsule Stations) Vol. 9 No. 3 222
Calculations Vol. 9 No. 3 224
Calcitriol 100 ng/mL Oral Liquid, Veterinary Vol. 9 No. 3 225
Dexamethasone Oral Powder 10-mg Units, Veterinary Vol. 9 No. 3 226
Dipyrone 500-mg/mL Injection, Veterinary Vol. 9 No. 3 227
Meloxicam 0.2 mg/mL Oral Liquid, Veterinary Vol. 9 No. 3 228
Methimazole 10-mg/mL Oral Liquid, Veterinary Vol. 9 No. 3 229
Metronidazole 1% and Silver Sulfadiazine 1% Cream, Veterinary Vol. 9 No. 3 230
Pergolide 500-mcg Capsules, Veterinary Vol. 9 No. 3 231
Pergolide 0.2-mg/mL Oral Liquid, Veterinary Vol. 9 No. 3 232
Phenoxybenzamine Hydrochloride 5-mg Capsules, Veterinary Vol. 9 No. 3 233
Piroxicam 2-mg/mL Oral Liquid, Veterinary Vol. 9 No. 3 234
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Vol. 9 No. 3 235
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Vol. 9 No. 3 238
Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Vol. 9 No. 3 242
PostScription: AVMA's Position on Compounding for Animals Vol. 9 No. 3 247
Prescription: Support Your Local College of Pharmacy Vol. 9 No. 4 250
Book Reviews: Awakening Athena: Resilience, Restoration, and Rejuvenation for Women Vol. 9 No. 4 252
Book Reviews: Perfect Balance Vol. 9 No. 4 253
Literature Reviews Vol. 9 No. 4 254
Testosterone Replacement Therapy for Female Androgen Insufficiency Syndrome Vol. 9 No. 4 259
Guidelines for Consulting with Patients about Bioidentical Hormone Replacement Therapy Vol. 9 No. 4 266
Hypothyroidism: Optimizing Therapy with Slow-Release Compounded Thyroid Replacement Vol. 9 No. 4 268
Compounding for Endocrine Disorders in Adult Patients Vol. 9 No. 4 275
Natural Progesterone Handout Vol. 9 No. 4 281
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products Vol. 9 No. 4 284
Local Ventilation for Safe Containment in the Pharmaceutical Industry Vol. 9 No. 4 293
Quality-Control Analytical Methods: Glossary of Quality Control/Quality Assurance Terms in Pharmaceutical Compounding Vol. 9 No. 4 300
Basics of Pharmacogenomics for the Compounding Pharmacist Vol. 9 No. 4 303
Calculations Vol. 9 No. 4 307
Standard Operating Procedure: Employee Personnel Records Vol. 9 No. 4 309
BMS Mouthwash Vol. 9 No. 4 310
Bonain's Solution Vol. 9 No. 4 311
Brompton's Mixture Vol. 9 No. 4 312
Bunnel's Solutions Vol. 9 No. 4 313
Burow's Solution Vol. 9 No. 4 314
Joulie's Solution Vol. 9 No. 4 315
Shohl's Solution, Modified (Albright's Solution) Vol. 9 No. 4 316
Suby-Albright Solution "G" Irrigation Vol. 9 No. 4 317
Suby-Albright Solution "M" Irrigation Vol. 9 No. 4 318
Whitehead's Varnish Vol. 9 No. 4 319
Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Vol. 9 No. 4 320
Stability of Nebulizer Admixtures Vol. 9 No. 4 323
PostScription: Women in Balance: A Cause Worth Advancing Vol. 9 No. 4 327
Prescription: Pharmacy Compounding Worldwide Vol. 9 No. 5 330
Book Reviews: Lawsuit Lottery: The Hijacking of Justice in America Vol. 9 No. 5 332
Literature Reviews Vol. 9 No. 5 333
Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Vol. 9 No. 5 339
Prescription for Relief: One Woman's Experience with Intractable Nonmalignant Pain Vol. 9 No. 5 349
A Patient's Guide to Transdermal Treatment of Pain Vol. 9 No. 5 354
Formulating for the Gluten-sensitive Individual Vol. 9 No. 5 357
Basics of Compounding: Using Chemical Conversion Factors Vol. 9 No. 5 361
Compounding: A Well-established Practice in 1938 Vol. 9 No. 5 364
Technology Update: An Overview of PDA-based Software Applications for Practicing Pharmacists Vol. 9 No. 5 369
Back to the Basics of Business Vol. 9 No. 5 380
Standard Operating Procedure: Denver Instrument Company M-120 Analytical Balance--Calibration, Cleaning, and Use Vol. 9 No. 5 382
Calculations Vol. 9 No. 5 384
Acetaminophen 400-mg, Aspirin 250-mg, Codeine Phosphate 30-mg with Antacids Capsules Vol. 9 No. 5 386
Acetaminophen 325-mg, Codeine Phosphate 32.5-mg, and Phenyltoloxamine Citrate 30-mg Capsules Vol. 9 No. 5 387
Aspirin 380-mg, Caffeine 30-mg, and Codeine Phosphate 30-mg Capsules Vol. 9 No. 5 388
Aspirin 325-mg, Codeine Phosphate 30-mg, Aluminum Glycinate 48.6-mg, and Magnesium Carbonate 97.2-mg Capsules Vol. 9 No. 5 389
Meperidine Hydrochloride 50-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 390
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 12.5-mg Capsules Vol. 9 No. 5 391
Meperidine Hydrochloride 50-mg and Promethazine Hydrochloride 25-mg Capsules Vol. 9 No. 5 392
Methadone Hydrochloride 0.33-mg/mL Oral Solution Vol. 9 No. 5 393
Morphine Sulfate 16-mg and Atropine Sulfate 0.4-mg/mL Injection Vol. 9 No. 5 394
Morphine Sulfate 5-mg/mL PCA Injection (Concentration May Vary) Vol. 9 No. 5 395
Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration Vol. 9 No. 5 396
Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion Vol. 9 No. 5 399
Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Vol. 9 No. 5 402
PostScription: Searching for Barrier Isolator Information? Vol. 9 No. 5 407
Prescription: Pediatric Formulation Initiatives Vol. 9 No. 6 410
Unlocking Autism: Is Compounding the Key? Vol. 9 No. 6 413
Compounding for a Pediatric Hospital Vol. 9 No. 6 423
Wiping Out Diaper Rash Vol. 9 No. 6 433
Pediatric Oral Liquid Preparations Vol. 9 No. 6 437
Marketing Your Business for Success Vol. 9 No. 6 445
Compounding Around the World: Portugal Vol. 9 No. 6 449
Profile: The McGuff Companies. Part 1: Compounding and Manufacturing Share Facilities and Build Corporate Success Vol. 9 No. 6 452
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Vol. 9 No. 6 456
Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products Vol. 9 No. 6 462
Standard Operating Procedure: Washing Glassware and Equipment Used in Compounding Nonsterile Preparations Vol. 9 No. 6 470
Calculations Vol. 9 No. 6 471
Alprazolam 1-mg/mL Oral Liquid Vol. 9 No. 6 472
Bethanechol 5-mg/mL Oral Liquid Vol. 9 No. 6 473
Clonazepam 0.1-mg/mL Oral Liquid Vol. 9 No. 6 474
Dolasetron 10-mg/mL Oral Liquid Vol. 9 No. 6 475
Ganciclovir 100-mg/mL Oral Liquid Vol. 9 No. 6 476
Isradipine 1-mg/mL Oral Liquid Vol. 9 No. 6 477
Pyrazinamide 10-mg/mL Oral Liquid Vol. 9 No. 6 478
Quinidine Sulfate 10-mg/mL Oral Liquid Vol. 9 No. 6 479
Ursodiol 25-mg/mL Oral Liquid Vol. 9 No. 6 480
Valganciclovir Hydrochloride 60-mg/mL Oral Liquid Vol. 9 No. 6 481
Chemical Stability of Fentanyl in Polypropylene Syringes and Polyvinylchloride Bags Vol. 9 No. 6 482
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Vol. 9 No. 6 484
PostScription: Compounding Pharmacies and the Successful Treatment of Autism Vol. 9 No. 6 487